期刊
CANCER CELL
卷 12, 期 3, 页码 239-251出版社
CELL PRESS
DOI: 10.1016/j.ccr.2007.07.002
关键词
-
资金
- NCI NIH HHS [CA73756, CA095644, CA75080, CA104397] Funding Source: Medline
- NIAID NIH HHS [AI35098] Funding Source: Medline
- NIDCR NIH HHS [2R01 DE013173-05] Funding Source: Medline
LZAP has been reported to inhibit cellular proliferation and clonogenic growth. Here, we report that decreased LZAP expression promoted cellular transformation, xenograft tumor growth, and xenograft tumor vascularity. Loss of LZAP also increased cellular invasion, and MMP-9 expression dependent on NF-kappa B. LZAP directly bound to ReIA, impaired serine 536 phosphorylation of ReIA, increased HDAC association with RelA, inhibited basal and stimulated NF-kappa B transcriptional activity, and was found at the promoter of selective NF-kappa B-responsive genes. LZAP protein levels were markedly decreased in 32% of primary HNSCCs (n = 28) and decreased LZAP levels in primary HNSCC correlated with increased expression of the NF-kappa B-regulated genes IL-8 and I kappa B alpha. In aggregate, these data support a role of LZAP in NF-kappa B regulation and tumor suppression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据